Diagnosis and management of chronic hepatitis B;Diagnostika a léčba chronické hepatitidy B

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 14, Issue 1, 2008, Pages 36-44

  Husa, Petr ^a   Plisek S ^b   Sperl J ^c   Urbanek P ^d   Galsky J ^e   Hulek P ^b   Kumpel P ^f   Nemecek V ^g   Volfova M ^h  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e Infek ni Odd lení   (Czech Republic)

^f Slezské Nemocnice Opava   (Czech Republic)

^g Narodni Referencni Laborator pro Hepatitidy Statniho Zdravotniho Ustavu   (Czech Republic)

^h Hepato Gastroenterologie HK s ro   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ALPHA2A INTERFERON; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD20 ANTIBODY; CLEVUDINE; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; NUCLEOSIDE ANALOG; PEGINTERFERON ALPHA2A; TELBIVUDINE; TENOFOVIR; TUMOR NECROSIS FACTOR ANTIBODY; VIRUS DNA;

ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARTICLE; CZECH REPUBLIC; DELTA AGENT HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGICAL TOLERANCE; KIDNEY FAILURE; LEUKOPENIA; MONOTHERAPY; NEPHROTOXICITY; NEUTROPENIA; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; TERATOGENICITY; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; VIRUS IDENTIFICATION; VIRUS REPLICATION; PRACTICE GUIDELINE;

HEPATITIS B, CHRONIC; HUMANS;

EID: 41549152053     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)